We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




HbA1c Test Underestimates Glucose Control in Hemodialysis Patients

By Labmedica staff writers
Posted on 25 Feb 2008
The standard hemoglobin A1c test (HbA1c) for estimating blood sugar control in people with diabetes is not accurate in those undergoing kidney hemodialysis.

HbA1c measures the percentage of hemoglobin (a protein in erythrocytes) that has reacted with glucose. More...
This measure, also known as glycosylated hemoglobin, generally reflects blood sugar control over the previous 30-120 days.

A study, performed by researchers at Wake Forest University Baptist Medical Center (Winston-Salem, NC, USA), evaluated the HbA1c test 307 patients with diabetes, 258 with end-stage kidney disease on hemodialysis, and 49 who did not have kidney failure. The standard HbA1c test was compared with a newer test (glycated albumin [GA]), which measures the amount of blood sugar that has reacted with albumin, a protein in the plasma. The GA test reflects blood sugar control over the previous three to four weeks. Blood samples were also analyzed to determine recent blood sugar levels.

Compared to those without kidney failure, diabetic patients on hemodialysis had higher blood sugars and GA levels, despite lower HbA1c results. The relationship between GA and HbA1c differed between diabetic dialysis patients and those without kidney disease, indicating that the HbA1c did not accurately reflect blood sugar control in those on hemodialysis.

The major reason for the discrepancy appears to be that HbA1c depends on erythrocyte survival and these cells do not live as long in hemodialysis patients. Most dialysis patients have anemia requiring treatment with medications that stimulate erythrocyte production (erythropoietin).

Controlling blood sugar is important because high levels are risk factors for developing atherosclerosis and lead to higher rates of kidney disease, heart attack, stroke, nerve damage, and blindness. People with diabetes who undergo hemodialysis are especially at high risk. About one out of four diabetic dialysis patients (23%) in the United States will die from cardiovascular and infection complications during their first year on dialysis, and only 31% survive five years.


Related Links:
Wake Forest University Baptist Medical Center

Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.